SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-004375
Filing Date
2021-06-16
Accepted
2021-06-16 16:05:13
Documents
12
Period of Report
2021-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_061621.htm   iXBRL 8-K 26400
  Complete submission text file 0001171843-21-004375.txt   200594

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crvs-20210615.xsd EX-101.SCH 3038
3 XBRL LABEL FILE crvs-20210615_lab.xml EX-101.LAB 34238
4 XBRL PRESENTATION FILE crvs-20210615_pre.xml EX-101.PRE 22367
5 EXTRACTED XBRL INSTANCE DOCUMENT f8k_061621_htm.xml XML 3727
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 211021504
SIC: 2834 Pharmaceutical Preparations